Betaxolol hydrochloride is a cardioselective β-adrenergic blocker, reportedly devoid
of intrinsic sympathomimetic and membrane stabilizing properties. Its long
duration of action permits once-daily dosing in mild to moderate hypertension. It
is also being evaluated in glaucoma.
Betaxolol (hydrochloride) (Item No. 26285) is an analytical reference standard categorized as a β1-adrenergic receptor antagonist. Formulations containing β-adrenergic receptor antagonists have been used to enhance physical performance in athletes. This product is intended for use in analytical forensic applications. This product is also available as a general research tool .
White or almost white, crystalline powder.
Betaxolol Hydrochloride, a cardioselective β1-adrenergic blocker. An antihypertensive; antiglaucoma.
ChEBI: The hydrochloride salt of betaxolol.
Betoptic (Alcon); Kerlone (Sanofi Aventis).
Selective β 1 -adrenoceptor antagonist.
